Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Andy Y. Lee"'
Autor:
Aaron Y. Kluger, Kristen M. Tecson, Andy Y. Lee, Edgar V. Lerma, Janani Rangaswami, Norman E. Lepor, Michael E. Cobble, Peter A. McCullough
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-13 (2019)
Abstract Background To summarize the four recent sodium-glucose cotransporter 2 inhibitor (SGLT2i) trials: Dapagliflozin Effect on CardiovascuLAR Events (DECLARE-TIMI 58), CANagliflozin CardioVascular Assessment Study (CANVAS) Program, Empagliflozin
Externí odkaz:
https://doaj.org/article/7c1bf642b14f4e52843d23ccc31bcfb6
Autor:
Kristen M. Tecson, Brian Lima, Andy Y. Lee, Fayez S. Raza, Grace Ching, Cheng‐Han Lee, Joost Felius, Ronald D. Baxter, Sasha Still, Justin D. G. Collier, Shelley A. Hall, Susan M. Joseph
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 11 (2018)
BackgroundVasoplegia is associated with adverse outcomes following cardiac surgery; however, its impact following left ventricular assist device implantation is largely unexplored. Methods and ResultsIn 252 consecutive patients receiving a left ventr
Externí odkaz:
https://doaj.org/article/32006399cdf3477282dd463063fe12a8
Publikováno v:
CASE.
Autor:
Binaya Basyal, Raja Zaghlol, Ezequiel J. Molina, Farooq H. Sheikh, Claudius Mahr, Ana Barac, Song Li, Ilana Schlam, Christopher Gallagher, Richard Cheng, Andy Y. Lee
Publikováno v:
JACC: CardioOncology
Background There are limited data to guide oncology and cardiology decision-making in patients with a left ventricular assist device (LVAD) and concurrent active malignancy. Objectives The goal of this study was to describe cancer treatment approache
Autor:
Gerald Watts, Farrah Deeba, David Sullivan, Paul Donald Bonnitcha, San San Min, Nimalie Jacintha Nanayakkara, Christopher Ebenbichler, Alexander Tschoner, Clemens Engler, Daniel Gaudet, Nathalie Roy, David Blackburn, Jean Bergeron, Hisee Villeneuve, Samir Saheb, Antonio Gallo, Sophia Beliard, Bertrand Dussol, Sophie Morange, Pascale Poullin, Rene Valero, Charalampos Milionis, Sebastian Filippas-Ntekouan, Eleftherios Klouras, Genovefa Kolovou, George Hatzigeorgiou, Spyridon Rammos, Paolo Rubba, Gabriella Iannuzzo, Mariko Harada-Shiba, Cheol Son, Hisashi Makino, Kiminori Hosoda, Kota Matsuki, Kyoko Kohmo, Masaki Matsubara, Masatsune Ogura, Michio Noguchio, Miki Matsuo, Ryo Koezuka, Tamiko Tamanaha, Tsutomu Tomita, Yoko Ohata, Yoshihiko Otsubo, Noriaki Koyanagi, Masaaki Kawashiri, Hayato Tada, Atsushi Nohara, Akihiro Nomura, Hirofumi Okada, Naohiko Fujii, Daisuke Hayashi, Sayoko Yonemoto, Shungo Fukuda, Koji Yanagi, Miwa Ryo, Masahiro Koseki, Makoto Nishida, Takeshi Okada, Erik Stroes, Laurens Reeskamp, Daniela Stols-Goncalves, Eva Hamulyak, Anho H Liem, Jurgen M Akkerhuis, Pieter R Nierop, Bastiaan M van Dalen, Sweder W E van de Poll, Adriana J M van Miltenburg-van Zijl, Marinus J Veerhoek, Frederick Raal, Sindeep Amrat Bhana, Olena Mitchenko, Vadym Romanov, Iryna Chulaevska, Leonid Rudenko, Olena Beregova, Igor Vakaliuk, Iryna Drapchak, Natalia Tymochko, Anna Isayeva, Olena Buriakovska, Maryna Vovchenko, Vira Tseluyko, Nataliya Matviychuk, Larysa Yakovleva, Paul Duell, Jonathan Barton Purnell, Robert Rosenson, Donald Smith, Theresa Halloran, Robert Gottlieb, Peter A McCullough, Zachary P Rosol, Andy Y Lee, Clay M Barbin, Seth J Baum, Reina Mendelson, Melissa Wright, Linda Hemphill, Akl Fahed, Traci Turner, Angela Ellard
Publikováno v:
New England journal of medicine, 383(8), 711-720. Massachussetts Medical Society
BACKGROUND: Homozygous familial hypercholesterolemia is characterized by premature cardiovascular disease caused by markedly elevated levels of low-density lipoprotein (LDL) cholesterol. This disorder is associated with genetic variants that result i
Autor:
Shelley A. Hall, Andy Y. Lee, Joost Felius, Brian Lima, Aldo E. Rafael, Gonzalo V. Gonzalez-Stawinski, Huanying Qin, Susan M. Joseph, Aayla K. Jamil, Fayez S. Raza, Amarinder Bindra
Publikováno v:
The American Journal of Cardiology. 122:1902-1908
Vasoplegia following cardiac transplantation is associated with increased morbidity and mortality. Previous studies have not accounted for primary graft dysfunction (PGD). The definition of vasoplegia is based on pressor requirement at 48 hours, many
Publikováno v:
Primary Care of the Solid Organ Transplant Recipient ISBN: 9783030506285
Heart transplantation for end-stage heart failure is an option in select patients for progressive cardiac pump failure, uncontrolled angina, or refractory ventricular tachycardia. With evolving surgical techniques and advances in immunosuppression si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92ee91742da659cc9139817ad561e59d
https://doi.org/10.1007/978-3-030-50629-2_6
https://doi.org/10.1007/978-3-030-50629-2_6
Publikováno v:
The American Journal of Cardiology. 124:316-318
Described herein is a 39-year-old man with systemic lupus erythematosus not receiving corticosteroid therapy who developed Libman-Sacks endocarditis causing stenosis of a bioprosthesis in the aortic valve position.
Autor:
Andy Y. Lee, Zachary Rosol, Norman E. Lepor, Aaron Y. Kluger, Clay M. Barbin, Janani Rangaswami, Kristen M. Tecson, Peter A. McCullough, Michael E. Cobble, Edgar V. Lerma
Publikováno v:
Reviews in cardiovascular medicine. 19(2)
In this systematic review, we sought to summarize the 3 recent sodium-glucose cotransporter 2 inhibitor (SGLT2i) trials (Dapagliflozin Effect on CardiovasculAR Events (DECLARE-TIMI 58), Canagliflozin Cardiovascular Assessment Study (CANVAS) Program,
Autor:
Janani Rangaswami, Sivan L. Kluger, Aaron Y. Kluger, Edgar V. Lerma, Zachary Rosol, Peter A. McCullough, Andy Y. Lee, Clay M. Barbin, Kristen M. Tecson
Publikováno v:
Reviews in cardiovascular medicine. 19(2)
Clinical trials of sodium glucose co-transporter 2 inhibitors (SGLT2i) in patients with type 2 diabetes and comorbid cardiovascular and kidney disease have shown reductions in major adverse cardiovascular events, heart failure hospitalizations, and a